Eli Lilly and Company
Strategic / Corporate InvestorLilly Corporate Center, United StatesSee on the maplilly.com
Eli Lilly and Company is a medicine company that develops and provides medicines and supports clinical trials across conditions including Alzheimer's disease, cancer, diabetes, and migraine.
- 3
- Portfolio companies on reccy
- 1
- Hiring now
- 12
- Open roles in the portfolio
- Jul 2026
- Latest portfolio round
Hiring now in the portfolio12
Apply on each company's site- Posted 5d ago
Senior Director, Data Management
Alto Neuroscience · Mountain View, CA
- Posted 24d ago
Senior Manager, Clinical Operations: People & Functional Leadership
Alto Neuroscience · Mountain View, CA
- Posted 1mo ago
Senior Manager/Director of Contracts and Procurement
Alto Neuroscience · Mountain View, CA
- Posted 1mo ago
Manager, Patient Recruitment & Engagement
Alto Neuroscience · Mountain View, CA
- Posted 1mo ago
VP, Commercial Planning
Alto Neuroscience · Mountain View, CA
- Posted 1mo ago
Clinical Trial Associate
Alto Neuroscience · Mountain View, CA
- Posted 2mo ago
Associate Director, Clinical Operations: People & Functional Leadership
Alto Neuroscience · Mountain View, CA
- Posted 2mo ago
Manager, Clinical Science & Site Educator
Alto Neuroscience · Remote (US)
Portfolio on reccy3
From company funding records- Series C · $45M · Nov 202312 roles
Alto Neuroscience
Los Altos, CA · Led a round · Series C · $45M · Nov 2023
- Corporate · Jul 2026None
ŌURA
Helsinki, Finland; Oulu, Finland; San Francisco, CA; San Diego, CA · Led a round · Corporate · Jul 2026
- Series A · $10M · Jul 2024None
RetiSpec
Toronto, Ontario, Canada · Led a round · Series A · $10M · Jul 2024
Their companies, round by round
From company funding records- Alto NeuroscienceLos Altos, CA
- Jul 2026Post-IPO Equity (PIPE) · $100M
- Mar 2026Post-IPO Equity (PIPE) · $120M
- Oct 2025Post-IPO Equity (PIPE) · $50M
- Jul 2024Grant · $11.7M
- Nov 2023Venture Round · $59.3M
- Nov 2023Series C · $45MLed
- ŌURAHelsinki, Finland; Oulu, Finland; San Francisco, CA; San Diego, CA
Wearables
- Jul 2026Series E
- Jul 2026CorporateLed
- Oct 2025Series E · $900M
- Sep 2025Debt · $250M
- Nov 2024Series D · $200M
- Apr 2022Venture Round
- RetiSpecToronto, Ontario, Canada
- Sep 2024Accelerator/Incubator
- Jul 2024Series A · $10MLed
- Apr 2023Grant
- Nov 2020Accelerator/Incubator
- Feb 2020Seed
- Nov 2019Seed · $250K
Rounds marked Led list Eli Lilly and Company as a lead investor; the rest are the company's other funding.
Recent rounds in the portfolio
- Jul 2026
ŌURA · CorporateLead
- Jul 2024
RetiSpec · Series A $10MLead
- Nov 2023
Alto Neuroscience · Series C $45MLead
With InVivium Capital, Franklin Templeton, Point72 Ventures, Alexandria Venture Investments
Portfolio in the news
From the Cortex · last 12 months- Mar 2026ŌURA enters India with Oura Ring 4, reveals how the country sleeps
ŌURA · The Economic Times
- Mar 2026